Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients

BACKGROUND: All-trans retinoic acid (ATRA)/anthracycline chemotherapy is beneficial in newly diagnosed acute promyelocytic leukemia (APL); however, it is important to identify patients with high-risk disease to increase the cure rate. We investigated the outcome of ATRA/anthracycline chemotherapy an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hong, Seung-Dok, Kim, Yeo-Kyeoung, Kim, Hee-Nam, Lee, Se Ryeon, Ahn, Jae-Sook, Yang, Deok-Hwan, Lee, Je-Jung, Lee, Il-Kwon, Shin, Myung-Geun, Kim, Hyeoung-Joon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065622/
https://ncbi.nlm.nih.gov/pubmed/21461300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/kjh.2011.46.1.24
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi